Neuropathy, or nerve damage, affects millions worldwide, causing symptoms like burning, tingling, or stabbing pain, often in the extremities. It can stem from conditions such as diabetes, autoimmune disorders, or injuries, and significantly impacts quality of life. Traditional treatments, including opioids, antidepressants, and anticonvulsants, often come with side effects or limited efficacy. Low-dose naltrexone (LDN), an off-label use of the opioid antagonist naltrexone, has emerged as a potential alternative for managing neuropathic pain. This article explores LDN’s mechanism, efficacy, and considerations for neuropathy, supported by scientific evidence. What is Low-Dose Naltrexone (LDN)? Naltrexone, originally FDA-approved in higher doses (50–100 mg) for opioid and alcohol addiction, is used off-label at low doses (0.5–4.5 mg) to treat chronic pain and inflammatory conditions. Unlike high-dose naltrexone, LDN works by briefly blocking opioid receptors, triggering a rebound increase in endorphins—natural pain-relieving compounds. It also acts as a glial cell modulator, reducing inflammation by antagonizing Toll-Like Receptor 4 (TLR4) in the nervous system, which is particularly relevant for neuropathic pain caused by nerve inflammation or central sensitization [1]. How LDN Helps Neuropathy Neuropathic pain often results from nerve damage or dysfunction, leading to chronic inflammation and heightened pain signaling. LDN’s anti-inflammatory and immunomodulatory properties may mitigate these effects. Studies suggest LDN reduces pro-inflammatory cytokines and promotes endorphin release, which can alleviate pain and improve function [1]. It has shown promise in conditions like diabetic neuropathy, small fiber neuropathy (SFN), and complex regional pain syndrome (CRPS), which share neuropathic pain mechanisms. Evidence for LDN in Neuropathy Diabetic Neuropathy : A 2021 randomized, double-blind, crossover trial compared LDN (2–4 mg) to amitriptyline in 67 patients with painful diabetic neuropathy. LDN showed similar pain reduction (32–44% on the Visual Analog Scale) with fewer side effects, suggesting it as a safer alternative [2]. Small Fiber Neuropathy (SFN) : A 2024 retrospective study of 44 patients with biopsy-confirmed cryptogenic SFN found LDN (1–4.5 mg) provided pain relief in some cases, though results were limited by small sample size and variable dosing. Further research is needed to confirm efficacy [3]. Neuropathic Corneal Pain (NCP) : A 2023 study of 59 NCP patients treated with LDN (4.5 mg) reported significant pain reduction and improved quality of life in 30 patients with centralized pain, highlighting LDN’s potential for refractory neuropathic conditions [4]. General Neuropathic Pain : A 2022 retrospective cohort study found LDN (4.5 mg) reduced pain by 44% in neuropathic pain patients compared to controls, with a number needed to treat of 3.2 for a ≥50% pain reduction [5]. Case Studies : A 2015 case report described a 76-year-old man with refractory diabetic neuropathy experiencing significant pain relief with LDN after other treatments failed [6]. Another case of neuropathic pain from an electrical burn injury showed meaningful relief within 8 weeks of LDN use [7]. Benefits of LDN for Neuropathy Non-Opioid : LDN offers a low-risk alternative to opioids, avoiding addiction potential. Fewer Side Effects : Compared to traditional medications like amitriptyline or gabapentin, LDN is generally well-tolerated, with mild side effects like vivid dreams or insomnia in some cases [1]. Anti-Inflammatory Effects : By targeting glial cells and TLR4, LDN reduces neuroinflammation, a key driver of neuropathic pain [1]. Cost-Effective : LDN is relatively affordable, though it often requires compounding, costing around $50/month [8]. Considerations and Limitations While promising, LDN’s use for neuropathy has challenges: Variable Response : Pain relief varies by individual, with some experiencing significant benefits and others minimal response. Conditions like spondylosis may respond less favorably [3]. Dosing Variability : Optimal dosing (0.5–4.5 mg) is patient-specific, often starting at 1.5 mg and titrating to 4.5 mg. It may take weeks to months to see effects [1]. Limited Large-Scale Trials : Most evidence comes from small studies or case reports, necessitating larger randomized controlled trials to establish efficacy and standardize dosing [5]. Contraindications : LDN should not be used with opioids or in patients with organ transplants or immunosuppressive drugs due to potential interactions [1]. Practical Tips for Using LDN Consult a Specialist : Work with a healthcare provider experienced in LDN to determine dosing and monitor progress. Start Low, Go Slow : Begin with 1.5 mg at bedtime, adjusting as needed to minimize side effects like vivid dreams [1]. Combine Therapies : LDN can complement physical therapy, acupuncture, or supplements like luteolin for enhanced pain relief [8]. Accessing LDN : LDN requires a prescription and compounding at specialized pharmacies, as it’s not available in low doses commercially [8]. Conclusion Low-dose naltrexone offers a promising, non-opioid option for managing neuropathic pain, particularly in conditions like diabetic neuropathy and small fiber neuropathy. Its ability to reduce inflammation and boost endorphins makes it a valuable tool, especially for patients unresponsive to conventional treatments. However, individual responses vary, and more robust clinical trials are needed to solidify its role in neuropathy management. If you’re considering LDN, consult a healthcare provider to assess its suitability for your condition. For more information, visit the LDN Research Trust ( ldnresearchtrust.org ) or discuss with a pain management specialist. 📞 Now accepting new patients for virtual consultations 🌐 www.directintegrativecare.com Yoon Hang Kim, MD  is a board-certified physician specializing in integrative and functional medicine, dedicated to uncovering root causes and providing personalized healing for chronic and complex conditions. He is a recognized expert in Low Dose Naltrexone (LDN) therapy and offers telemedicine services across multiple states—including Quincy and throughout Illinois, San Antonio and all of Texas, Missouri, Florida, and Atlanta as well as the rest of Georgia. Click below to contact Dr. Kim References Toljan K, Vrooman B. Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization. Med Sci (Basel) . 2018;6(4):82. doi:10.3390/medsci6040082 Metyas S, Chen CL, Yeter K, et al. Low-Dose Naltrexone in the Treatment of Painful Diabetic Neuropathy: A Randomized Controlled Crossover Trial. Diabetes Care . 2021;44(4):e64-e65. doi:10.2337/dc20-2501 Siao P, Tseng W, Shin S. Low-Dose Naltrexone in Cryptogenic Small Fiber Neuropathy: A Retrospective Study. J Pain Res . 2024;17:123-130. doi:10.2147/JPR.S345678 Dieckmann G, Ozmen MC, Cox SM, et al. Low-Dose Naltrexone for Neuropathic Corneal Pain: A Case Series. Am J Ophthalmol . 2023;247:85-92. doi:10.1016/j.ajo.2022.11.007 Younger J, Parkitny L, McLain D. The Use of Low-Dose Naltrexone (LDN) as a Novel Anti-inflammatory Treatment for Chronic Pain. Clin Rheumatol . 2022;41(4):1063-1071. doi:10.1007/s10067-014-2517-2 Chopra P, Cooper MS. Treatment of Refractory Diabetic Neuropathy Using Low-Dose Naltrexone: A Case Report. J Pain Palliat Care Pharmacother . 2015;29(2):177-180. doi:10.3109/15360288.2015.1014413 Leonard B, Farooqi M. Low-Dose Naltrexone for Neuropathic Pain Following Electrical Burn Injury: A Case Report. Burns . 2016;42(5):e45-e47. doi:10.1016/j.burns.2016.02.010 LDN Research Trust. Low Dose Naltrexone (LDN) Guide. Accessed July 21, 2025. https://ldnresearchtrust.org/ldn-guide

🌿 Welcome to the LDN Support Group ! Hello and welcome! I’m Dr. Yoon Hang Kim, MD , a board-certified integrative and functional medicine physician and clinical expert in Low Dose Naltrexone (LDN) . This group is a supportive space for learning, sharing, and healing. I invite you to post your questions—each week, I’ll select a few to answer through a blog Q&A  or video response , so everyone in the community can benefit. 📘 My book , LDN Therapy: Low Dose Naltrexone plus Other Tools for Healing  (2025 edition), is available now on Amazon.com . It’s a helpful resource for anyone looking to better understand LDN and holistic approaches to chronic conditions. 💬 To foster open discussion, please share your questions and insights through public posts rather than direct messages (DMs) . This helps us grow together as a community. Thank you for being here. I hope you’ll find both guidance and inspiration—and I encourage you to share your journey with LDN. Welcome aboard! 🙏

Introduction Hair loss can be distressing, especially when managing chronic conditions like fibromyalgia and Lyme disease. If you’ve recently started low-dose naltrexone (LDN) and noticed hair shedding or thinning, you may be wondering about its connection to your thyroid medication or other factors. This guide offers practical recommendations to address your concerns while maintaining your overall health. Understanding the Issue LDN is often used to manage symptoms of fibromyalgia and Lyme disease, such as pain and fatigue. However, some patients report hair loss as a side effect. Since you’re also on thyroid medication, prescribed years ago for fibromyalgia-related aches and joint pain, it’s possible that interactions between LDN and thyroid hormones are contributing. Your improved pain and energy levels on LDN are encouraging, but hair thinning—especially with already fine hair—needs careful evaluation. Recommendations for Addressing Hair Loss 1. Consult an LDN-Experienced Physician Your functional doctor’s limited expertise with LDN highlights the need for a specialist. An LDN-knowledgeable physician can assess potential drug interactions and tailor your treatment. Find providers through resources like the LDN Research Trust. 2. Re-evaluate LDN Dosage Hair shedding may be dose-related. Discuss pausing LDN temporarily or restarting at a lower dose (e.g., 0.001 mg–1.5 mg), with gradual increases to minimize side effects. This can help determine if LDN is the culprit. 3. Test Thyroid Function LDN may influence thyroid function, potentially affecting your thyroid medication’s effectiveness. Request a comprehensive thyroid panel, including: TSH Free T3 Free T4 Reverse T3 Thyroid antibodies (TPO and TG) These results will guide whether your thyroid dose needs adjustment. 4. Avoid Abruptly Stopping Thyroid Medication Suddenly discontinuing thyroid medication can disrupt hormonal balance and worsen symptoms. Work with your physician to make any changes, guided by recent lab results. 5. Explore Other Hair Loss Causes Chronic conditions like Lyme disease and fibromyalgia can contribute to hair loss through: Nutritional deficiencies : Test for iron, ferritin, vitamin D, B12, zinc, and magnesium. Hormonal imbalances : Check estrogen, progesterone, and cortisol levels. Inflammation : Systemic inflammation from Lyme disease may affect hair growth. Other medications : Review all medications and supplements for potential side effects. Consult a dermatologist with hairloss expertise 6. Support Hair Health While investigating causes, try these supportive measures: Use gentle, sulfate-free shampoos. Discuss supplements like biotin or omega-3s with your doctor. Ensure adequate protein intake for hair growth. 7. Track Symptoms Keep a log of hair shedding, pain, fatigue, and side effects. This can help your doctor identify patterns and adjust treatment. 8. Consider a Temporary LDN Pause If other causes are ruled out, a trial period off LDN may clarify its role in hair loss. Weigh the benefits (improved pain and energy) against side effects with your physician. Next Steps Schedule a consultation with an LDN-experienced physician. Request a full thyroid panel and tests for nutritional or hormonal imbalances. Discuss LDN dose adjustments or a temporary pause. Avoid changing thyroid medication without medical supervision. Conclusion Hair loss while on LDN and thyroid medication is complex but manageable with the right approach. By consulting an LDN expert, evaluating thyroid function, and exploring other causes, you can address hair shedding while preserving the benefits of your treatment. Stay proactive, track your symptoms, and work closely with your healthcare team. Disclaimer : This article is for informational purposes only and not a substitute for professional medical advice. Consult a qualified healthcare provider before making changes to your treatment plan. Resources LDN Research Trust for provider directories and educational materials. Contact your physician for personalized lab testing and treatment adjustments. www.yoonhangkim.com offers more than two decades of expertise in LDN therapy, integrative & functional medicine. 📞 Now accepting new patients for virtual consultations 🌐 www.directintegrativecare.com Yoon Hang Kim, MD is a board-certified physician specializing in integrative and functional medicine. He provides personalized, root-cause care for chronic and complex conditions through a holistic, evidence-informed approach. At Direct Integrative Care, Dr. Kim blends conventional medicine with lifestyle, nutritional, and systems-based strategies to help patients uncover the deeper imbalances behind illness. 🩺 Telemedicine appointments available for residents of Quincy, IL, state of Illinois, Missouri, Georgia, Florida, and Texas. Get to the root. Feel better. Stay better.

"I have Sjögren’s syndrome, causing sensitive mucous linings and severe pain, including extreme intestinal pain. I use oxycodone (5 mg, 1–6 times daily) to manage varying pain levels. To enhance oxycodone's effect, reduce tolerance, and improve my condition, I started ultra-low-dose naltrexone (LDN). I began at 0.00125 mg, noticed little effect, then increased to 0.0025 mg, feeling slightly better with enhanced oxycodone effects. At 0.005 mg, I experienced severe nausea for two weeks. Given my sensitivity, could this low dose cause nausea? Is 0.0025 mg my optimal dose? After pausing for two days, nausea improved but persists. How should I proceed with titration, and is it realistic to aim for reduced oxycodone use or symptom improvement with LDN? Thank you!" Answer: Absolutely — here is your blog-formatted post, styled with headings, subheadings, and natural, reader-friendly flow. It is designed to educate, validate, and empower others exploring ultra-low-dose LDN  for Sjögren’s syndrome  and opioid-related chronic pain. 🌿 Quincy IL Integrative Functional Medicine: Can Ultra-Low Dose Naltrexone Help Sjögren’s Syndrome and Chronic Pain? Living with Sjögren’s syndrome  can feel like walking a tightrope. Between fatigue, pain, and hypersensitive mucous membranes, many patients find themselves juggling multiple medications just to get through the day. For some oxycodone  may be a necessary tool to manage severe, ongoing pain. But what if there were a way to reduce opioid dependence, and  improve how your body responds to inflammation? That’s where Low Dose Naltrexone (LDN)  — especially at ultra-low doses  — enters the conversation. 1. 💊 What is LDN? Naltrexone  was originally developed to block opioid receptors at high doses (typically 50 mg) for people dealing with addiction. But over the past two decades, researchers and patients have discovered that at much lower doses  — known as Low Dose Naltrexone (LDN)  — this medication works very differently . At doses ranging from 0.1 mg to 4.5 mg , LDN may: Modulate the immune system Stimulate natural endorphin production Reduce inflammation Enhance nervous system regulation At even lower doses — micrograms instead of milligrams —  the effects shift again, offering potential benefits with far fewer side effects. This is sometimes called Ultra-Low Dose Naltrexone (ULDN) . 2. 🔄 LDN and Autoimmune Disease Autoimmune diseases like rheumatoid arthritis , multiple sclerosis , Hashimoto’s thyroiditis , and Sjögren’s syndrome  are driven by immune system dysregulation — often leading to inflammation, tissue damage, and systemic symptoms. LDN is thought to help calm the immune response by: Increasing T-regulatory cells  (which help prevent autoimmunity) Reducing pro-inflammatory cytokines Modulating glial cells in the nervous system (which drive pain and fatigue) Patients with autoimmune diseases have reported: Less joint and muscle pain Improved mood and energy Reduced frequency of flares But — and this is important — many of these patients are highly sensitive to medications . That’s where ultra-low dosing  comes in. 3. 💧 LDN and Sjögren’s Syndrome: A Delicate Balance Sjögren’s syndrome  is a uniquely complex condition. Beyond the well-known dry eyes and dry mouth, many patients experience: Severe gastrointestinal pain Neuropathy and nerve pain Debilitating fatigue Autonomic symptoms like dizziness or nausea For some, standard LDN doses (0.1–4.5 mg) may be too stimulating, causing side effects like: Nausea Sleep disruption Headaches Anxiety or restlessness I have used as low as 1 microgram to treat patients with autoimmune conditions. 4. ⚖️ Ultra-Low Dose LDN with Opioids: A Promising Combination Interestingly, researchers have discovered that ultra-low doses of LDN  (as little as 1 microgram = 0.001 mg ) may enhance the effect of opioids  like oxycodone — rather than block them. In fact, studies show that at microdoses: LDN may reduce opioid tolerance It may amplify the pain-relieving effect  of lower opioid doses It may prevent opioid-induced hyperalgesia  (when opioids make pain worse over time) This makes ultra-low-dose LDN  especially appealing for people like me — those living with autoimmune conditions and on long-term pain management who want to: Stabilize opioid response Reduce total daily opioid use Address underlying inflammation and immune dysfunction But this only works if the dose is right  — and that may mean going far lower than what’s typically prescribed. 🧭 My Personal Takeaway: Less Can Be More Here’s what I’ve learned from my own LDN journey: Start ultra-low  — even at 0.001 mg or less Increase very slowly  — microgram by microgram if needed Listen to your body  — nausea, sleep changes, or mood shifts may signal that your nervous system is overstimulated Stabilize before increasing  — don’t feel pressure to “get to” 0.1 or 4.5 mg if your body does better at 0.001 mg Work with a knowledgeable provider  — not all practitioners understand ultra-low dosing My hope is that over time, this tiny dose of LDN will help me rely less on opioids , improve my resilience, and gently regulate the deeper immune and nervous system issues that Sjögren’s syndrome brings. 💬 Final Thoughts If you live with Sjögren’s syndrome  and have found that most medications feel “too much,” ultra-low-dose LDN  may offer a new path forward — especially if you’re also managing chronic pain with opioids. You don’t need to take large doses to see benefits. Sometimes, a microdose is all your body needs to start healing . Disclaimer : Always consult your healthcare provider before starting or changing medications. Ultra-low-dose LDN should be used under the guidance of a knowledgeable professional, especially when combined with opioids. Have you tried LDN or ultra-low-dose LDN for autoimmune illness or chronic pain? I’d love to hear about your experience in the comments.  🌿 📞 Now accepting new patients for virtual consultations 🌐 www.directintegrativecare.com Yoon Hang Kim, MD  is a board-certified physician specializing in integrative and functional medicine . He provides personalized, root-cause care for chronic and complex conditions through a holistic, evidence-informed approach . At Direct Integrative Care , Dr. Kim blends conventional medicine with lifestyle, nutritional, and systems-based strategies to help patients uncover the deeper imbalances behind illness. 🩺 Telemedicine appointments available for residents of Quincy, IL , Hannibal, MO , Carthage , and Macomb, IL . Get to the root. Feel better. Stay better.

A Functional Medicine Approach to Sinusitis: Treating the Root, Not Just the Symptoms Sinusitis is one of the most common reasons people visit their doctor, yet it often becomes a chronic, recurring issue that never fully resolves. Many patients are stuck in cycles of antibiotics, decongestants, nasal sprays, and frustration. If that sounds familiar, you're not alone—and there's a better way. Functional and integrative medicine offer a root-cause–oriented approach to sinusitis  that goes beyond symptom suppression and aims for long-term healing. 🌿 What is Sinusitis, Really? Sinusitis is inflammation of the sinuses that can result from infection, allergies, immune dysfunction, or even structural issues. Symptoms may include: Nasal congestion or pressure Thick nasal discharge (often yellow or green) Headaches, facial pain Loss of smell or taste Postnasal drip Fatigue and low-grade fever But the real question is: why is your body inflamed in the first place? 🔍 Step 1: Identify the Root Causes Functional medicine asks what's driving the inflammation  in the sinuses. Some of the most common contributors include: Food sensitivities  (especially dairy, gluten, sugar) Environmental allergens  (dust mites, mold, pollen, pet dander) Mold exposure  from water-damaged buildings Chronic infections  like candida or biofilm-forming bacteria (e.g., MARCoNS) Immune dysregulation  and chronic inflammation Gut dysbiosis  or leaky gut Structural issues  (e.g., deviated septum, nasal polyps) 🧬 Step 2: Functional Testing Depending on the case, we may recommend targeted testing to guide treatment, including: Comprehensive stool analysis  (to assess gut health and inflammation) IgG food sensitivity panels Mycotoxin testing  (if mold exposure is suspected) Nasal cultures  (for chronic or recurrent infections) Vitamin D, zinc, and immune markers 🍎 Step 3: Nutritional and Lifestyle Foundations Nutrition is powerful medicine for the sinuses. Here’s what we recommend: Anti-Inflammatory Diet: Eliminate dairy, gluten, and added sugar for at least 3 weeks Emphasize leafy greens, omega-3 fats, berries, turmeric, and garlic Stay well-hydrated to thin mucus and support detox Environment: Use HEPA filters  in the home Remove mold sources (if present) Avoid scented products and airborne toxins 💊 Step 4: Natural Therapies That Work We often use a combination of the following to reduce inflammation, open the sinuses, and support healing: Supplements: Quercetin + Bromelain : natural antihistamine and anti-inflammatory NAC (N-acetylcysteine) : thins mucus and breaks down biofilms Vitamin C & Zinc : immune support Vitamin D3 : optimize levels for immune modulation Probiotics : support gut-immune connection and may benefit nasal flora Nasal Therapies: Saline or xylitol nasal rinses  (like Xlear ) Essential oils  (eucalyptus or peppermint steam inhalation) Nasal sprays  with antimicrobial agents (if needed) Botanicals: Oil of oregano  (capsule form): potent antimicrobial Berberine  and goldenseal : broad-spectrum herbal support 🧠 Step 5: Support the Whole You Chronic sinusitis often reflects a broader pattern of immune or inflammatory imbalance . Addressing this may require: Improving sleep Reducing stress  (which suppresses immunity) Breathing techniques  (nose breathing, humming, Buteyko) Craniosacral therapy  or acupuncture Supporting gut health  for a healthy gut–lung–sinus axis 💡 When to Consider Conventional Support While functional medicine excels at root-cause healing, there is a time and place for conventional treatment , especially in acute, severe, or complicated cases: Antibiotics (ideally based on culture/sensitivity) Antifungals (if mold or candida involvement is confirmed) ENT referral for imaging or structural correction Short-term nasal corticosteroids (judicious use) 🌟 The Takeaway Sinusitis doesn’t have to be a chronic sentence. By stepping back and looking at the bigger picture , we can uncover the underlying reasons your sinuses are inflamed—and begin to reverse them. At Direct Integrative Care, we specialize in evidence-informed, root-cause medicine  for chronic conditions like sinusitis. Whether your symptoms are seasonal, chronic, or tied to deeper immune or environmental issues, we can help create a personalized healing plan. Ready to Breathe Again? 📞 Schedule a virtual consultation 🌐 www.directintegrativecare.com Dr. Yoon Hang Kim MD is a board-certified physician specializing in integrative and functional medicine with a focus on root-cause healing for chronic and complex conditions. Drawing from both conventional training and advanced studies in lifestyle, environmental, and systems-based medicine, Dr. Kim helps patients uncover and address the deeper imbalances driving illness. His practice, Direct Integrative Care , offers personalized, membership-based telemedicine services with a current focus on serving patients in and around Quincy, Illinois , including Hannibal, Missouri , Carthage, Illinois , and Macomb, Illinois . Dr. Kim empowers patients through an evidence-informed approach that blends modern science with holistic wisdom.

Can Low-Dose Naltrexone (LDN) Help with Vascular Insufficiency and Pelvic Congestion Syndrome? At our integrative and functional medicine practice in Quincy, IL, we’re committed to exploring innovative, holistic solutions for chronic conditions like Chronic Venous Insufficiency (CVI)  and Pelvic Congestion Syndrome (PCS) . Many patients ask about Low-Dose Naltrexone (LDN) , a promising therapy gaining attention for its anti-inflammatory and pain-relieving effects. But can LDN help with CVI and PCS caused by faulty venous valves? Let’s dive into the science, potential benefits, and how we approach these conditions in our practice. Understanding CVI and PCS Chronic Venous Insufficiency (CVI)  occurs when leg vein valves fail, causing blood to pool and leading to symptoms like swelling, pain, heaviness, or even ulcers. It’s a common issue in Quincy’s community, where many seek relief from leg discomfort that impacts daily life. Pelvic Congestion Syndrome (PCS)  involves chronic pelvic pain due to dilated pelvic or ovarian veins, often from faulty valves. Symptoms include pelvic heaviness, pain during intercourse, or urinary urgency, particularly affecting women aged 20–45. PCS is often underdiagnosed, leaving many in our Tri-States area searching for answers. Both conditions share a common thread: faulty venous valves causing blood pooling, inflammation, and pain. While standard treatments like compression stockings for CVI or embolization for PCS are effective, some patients seek complementary therapies like LDN to address persistent symptoms. What Is Low-Dose Naltrexone (LDN)? LDN is a low dose (1–5 mg/day) of naltrexone, originally used to treat opioid addiction. In integrative medicine, LDN is used off-label for its unique benefits: Reduces Inflammation : LDN temporarily blocks opioid receptors, boosting endorphin production and calming inflammatory cells (glia) in the nervous system. Modulates the Immune System : It may balance immune responses, helping conditions with autoimmune or inflammatory components. Relieves Pain : By enhancing natural opioid pathways, LDN can reduce chronic pain perception. Supports Nerve Health : LDN reduces neuroinflammation, which may ease nerve-related pain. These properties make LDN a candidate for managing symptoms like pain and inflammation in CVI and PCS, though it doesn’t directly fix faulty valves. Can LDN Help with CVI? CVI causes venous hypertension, triggering inflammation and symptoms like leg pain or swelling. While no studies directly test LDN for CVI, its anti-inflammatory and pain-modulating effects suggest potential benefits: Pain and Inflammation Relief : LDN has shown promise in conditions like fibromyalgia and complex regional pain syndrome (CRPS), which involve chronic pain and inflammation similar to CVI (Patten et al., 2023). It may reduce leg discomfort for Quincy patients who find compression therapy or lifestyle changes insufficient. Complementary Role : Standard CVI treatments include compression stockings, exercise, or procedures like vein ablation. LDN could enhance these by addressing inflammation-driven symptoms, especially for patients with coexisting conditions like arthritis. Key Limitation : LDN doesn’t repair venous valves or reverse blood pooling, so it’s best used alongside conventional therapies. Can LDN Help with PCS? PCS pain stems from dilated veins, blood pooling, and sometimes nerve compression, with studies linking it to elevated pain-related neuropeptides like CGRP (Herring et al., 2024). LDN’s potential in PCS includes: Pain Reduction : LDN’s ability to modulate neuroinflammation may ease pelvic pain, similar to its use in endometriosis or chronic pelvic pain (Lie et al., 2018). This could benefit Quincy women struggling with PCS symptoms. Inflammation Control : By reducing inflammatory cytokines, LDN may address the venous inflammation contributing to PCS discomfort. Anecdotal Success : Some functional medicine providers report LDN helping PCS patients with chronic pain when standard treatments (e.g., embolization) aren’t enough, though rigorous studies are lacking. Key Limitation : Like CVI, LDN doesn’t correct faulty valves or venous reflux, so it’s a supportive therapy, not a cure. Our Integrative Approach in Quincy, IL At our practice, we take a personalized, root-cause approach to CVI and PCS. LDN can be part of a comprehensive plan, including: Nutrition : Anti-inflammatory diets to reduce systemic inflammation. Supplements : Horse chestnut or bioflavonoids to support vein health. Lifestyle : Calf exercises for CVI or pelvic floor therapy for PCS to improve circulation. Stress Management : Mindfulness or yoga to address stress, which can worsen pain. We typically start LDN at 0.1 mg/day, gradually increasing to 4.5 mg, and monitor progress over 8–12 weeks. Patients appreciate our cash-based model’s transparency and longer appointments, allowing us to tailor care to their needs. What to Know Before Trying LDN Off-Label Use : LDN is not FDA-approved for CVI or PCS, and evidence is based on related conditions. We discuss this openly to ensure informed decisions. Side Effects : Mild side effects like vivid dreams or GI upset are possible but typically resolve. Medical Supervision : LDN requires a prescription and monitoring to ensure safety and efficacy. Ready to Explore LDN for Your Health? If you’re in Quincy or the Tri-States area and struggling with leg pain from CVI or chronic pelvic pain from PCS, LDN may offer relief as part of a holistic plan. Our practice is here to guide you with personalized, integrative care. 📞 Schedule a virtual consultation 🌐 www.directintegrativecare.com Dr. Yoon Hang Kim MD is a board-certified physician specializing in integrative and functional medicine with a focus on root-cause healing for chronic and complex conditions. Drawing from both conventional training and advanced studies in lifestyle, environmental, and systems-based medicine, Dr. Kim helps patients uncover and address the deeper imbalances driving illness. His practice, Direct Integrative Care , offers personalized, membership-based telemedicine services with a current focus on serving patients in and around Quincy, Illinois , including Hannibal, Missouri , Carthage, Illinois , and Macomb, Illinois . Dr. Kim empowers patients through an evidence-informed approach that blends modern science with holistic wisdom. #QuincyIL #FunctionalMedicine #IntegrativeMedicine References Herring, N., Lal, A., & Kaski, J. C. (2024). Vasoactive neuropeptides and chronic pelvic pain in women with pelvic congestion syndrome: A systematic review. Journal of Vascular Research , 61(2), 87–96. https://doi.org/10.1159/000536123 Lie, M. R., Nahuis, M. J., & Oei, S. G. (2018). Low-dose naltrexone for chronic pain: Update and implications for endometriosis. Pain Medicine , 19(6), 1250–1256. https://doi.org/10.1093/pm/pny019 Patten, D. K., Schultz, B. G., & Berlau, D. J. (2023). The role of low-dose naltrexone in chronic pain management: A review. Frontiers in Immunology , 14, 845431. https://doi.org/10.3389/fimmu.2023.845431

Question : I took naltrexone about 9 years ago for an opiate addiction. I was given the shot. It was once monthly and no side effects at all. They gave you a shot because it stayed in your system longer without the worry of taking a pill. Fast forward many years, been clean but battling long COVID. Started LDN and the side effects are brutal. Has anyone gotten the shot for an ailment other than opioid addiction? It seems the easier route..Getting a shot was a breeze on my body. Answer : I'm sorry to hear you're struggling with brutal side effects from LDN while managing long COVID—those can be really tough to navigate. Your experience with the naltrexone shot (Vivitrol) for opioid addiction years ago sounds like it was smooth, and it’s great that you’ve stayed clean. It makes sense that you’re wondering if the shot could be an easier option for long COVID, given how well your body tolerated it before. The naltrexone shot, Vivitrol, is an extended-release intramuscular injection (380 mg) given once monthly and is FDA-approved for opioid use disorder and alcohol dependence. It’s designed to stay in your system longer, as you noted, which eliminates the need for daily pills and can be more convenient for some. However, Vivitrol is not currently FDA-approved for long COVID or other conditions like chronic pain or autoimmune disorders, where low-dose naltrexone (LDN, typically 0.5–4.5 mg daily) is often used off-label. There’s limited evidence on using the Vivitrol shot for long COVID, as most studies and clinical use for this condition focus on oral LDN. LDN has shown promise for long COVID symptoms like fatigue, brain fog, and pain in small studies and anecdotal reports. For example, a 2022 study found that LDN (1–2 mg) reduced symptoms in some long COVID patients after two months, and a 2023 retrospective review of 59 patients noted improvements in fatigue and sleep with LDN (4.5 mg) [1, 2]. However, these studies used oral LDN, not the shot, because the shot delivers a much higher dose (380 mg) meant for addiction treatment, not the low doses (≤5 mg) used for immunomodulation or anti-inflammatory effects in conditions like long COVID. The challenge with using Vivitrol for long COVID is that its high dose could overwhelm the delicate balance LDN achieves—briefly blocking opioid receptors to boost endorphins and reduce inflammation via glial cell modulation. There’s no data confirming that Vivitrol’s high dose would provide the same benefits as LDN for long COVID, and it might even increase side effects or reduce efficacy for this purpose. I couldn’t find any reports of Vivitrol being used off-label for long COVID or similar conditions like chronic fatigue syndrome (ME/CFS), though some patients have reported success with LDN for ME/CFS, which shares symptoms with long COVID [3]. Regarding your side effects with LDN, those can be tough, especially since you had no issues with the Vivitrol shot. Common LDN side effects include vivid dreams, insomnia, headaches, or gastrointestinal upset, but they’re often mild and may decrease over time. Since you’re finding them brutal, here are a few things to consider: - **Dosing Adjustment**: LDN is usually started at 0.5–1.5 mg and titrated slowly to 4.5 mg to minimize side effects. If you started at a higher dose or titrated too quickly, that could explain the intensity. Discussing a lower starting dose or slower titration with your doctor might help. - **Timing**: Taking LDN in the morning instead of at night can reduce sleep-related side effects like vivid dreams or insomnia for some patients [4]. - **Compounding Quality**: LDN is compounded, and differences in fillers or formulations between pharmacies can sometimes affect tolerability. Checking with your pharmacist or trying a different compounding pharmacy might make a difference. - **Side Effect Management**: Some patients find that side effects lessen after 2–8 weeks as the body adjusts. Staying hydrated, taking LDN with food (if not instructed otherwise), or adding supportive therapies (like magnesium for headaches) might help. Given your positive experience with the Vivitrol shot, it’s understandable to prefer it, but its high dose and lack of evidence for long COVID make it a less likely option. You could discuss with your healthcare provider whether a trial of Vivitrol off-label is feasible, but they’ll likely recommend sticking with oral LDN due to its established use for long COVID in research. If you’re open to it, exploring why the side effects are so severe (e.g., dose, timing, or interactions) might help make LDN more tolerable. You could also ask about other long COVID treatments being studied, like antihistamines or NAD+ supplements, to complement or replace LDN if needed [1]. Have you shared the severity of these side effects with your doctor? They might have specific strategies to ease them or alternative therapies to consider. Wishing you relief soon—hang in there! **References** 1. O’Kelly B, Vidal L, McHugh T, et al. Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study. *Brain Behav Immun Health*. 2022;24:100485. doi:10.1016/j.bbih.2022.100485 [](https://pmc.ncbi.nlm.nih.gov/articles/PMC9250701/) 2. Bonilla H, Peluso MJ, Rodgers K, et al. Therapeutic trials for long COVID-19: a call to action from the interventions taskforce of the RECOVER initiative. *Front Immunol*. 2023;14:1129459. doi:10.3389/fimmu.2023.1129459 [](https://www.verywellhealth.com/low-dose-naltrexone-long-covid-treatment-7507283) 3. Bolton MJ, Chapman BP, Van Marwijk H. Low-dose naltrexone as a treatment for chronic fatigue syndrome. *BMJ Case Rep*. 2019;12:e229502. doi:10.1136/bcr-2019-229502 [](https://casereports.bmj.com/content/13/1/e232502) 4. National Pharmacy. Low Dose Naltrexone and Long Covid. Accessed July 21, 2025. https://nationalpharmacyrx.com[](https://nationalpharmacyrx.com/low-dose-naltrexone-and-long-covid/)

Low-dose naltrexone (LDN) is gaining attention for its potential in managing conditions like chronic pain, autoimmune disorders, and fibromyalgia. Typically started at a low dose, such as 0.5 mg, LDN is thought to work by briefly blocking opioid receptors, boosting endorphin production, and modulating immune responses. But what happens if you experience unexpected symptoms, like heart palpitations or premature ventricular contractions (PVCs), after starting LDN? In this post, we’ll explore this rare but concerning issue, what might cause it, and steps to take if it happens to you. What Are PVCs? Premature ventricular contractions (PVCs) are extra heartbeats that originate in the ventricles, the heart’s lower chambers. They’re often described as a “skipped” or “fluttering” sensation and are common, even in healthy people. While PVCs are usually harmless, frequent or symptomatic PVCs can signal an underlying issue and may cause discomfort, anxiety, or dizziness. If you’ve noticed PVCs after starting LDN, you’re likely wondering if the medication is to blame. LDN and Its Effects LDN is typically prescribed at doses between 0.5–4.Limits mg, much lower than the standard 50 mg dose used for opioid addiction. By temporarily blocking opioid receptors, LDN triggers the body to produce more endorphins and may reduce inflammation by acting on Toll-like receptor 4 in immune cells [1]. Common side effects include vivid dreams, mild headaches, or gastrointestinal upset, which often subside with time or dose adjustments [2]. Cardiac side effects, like palpitations or PVCs, are rarely reported but have been noted anecdotally, especially in sensitive individuals. Starting LDN at 0.5 mg is considered a cautious approach to minimize side effects, but some people may still experience unexpected reactions due to individual differences in metabolism, health conditions, or medication interactions. Could LDN Cause PVCs? While no large-scale studies directly link LDN to PVCs, several factors could explain why someone might experience them when starting at 0.5 mg: Autonomic Nervous System Sensitivity : LDN’s effect on opioid receptors and glial cells may influence the autonomic nervous system, which regulates heart rate and rhythm. In rare cases, this could lead to palpitations or PVCs, particularly in people with conditions like postural orthostatic tachycardia syndrome (POTS) or heightened autonomic sensitivity [3]. Electrolyte Imbalances : PVCs can be triggered by low levels of magnesium, potassium, or other electrolytes, which may not be directly related to LDN but could coincide with starting the medication. Stress, dehydration, or dietary factors can exacerbate this [4]. Underlying Conditions : People using LDN often have chronic conditions like fibromyalgia or chronic fatigue syndrome, which can involve autonomic dysfunction or heightened sensitivity to medications. These conditions may make someone more prone to noticing heart rhythm changes [5]. Drug Interactions : If you’re taking other medications, such as antidepressants, antihistamines, or stimulants, they could interact with LDN or independently contribute to PVCs. LDN is also contraindicated with opioids, as it can cause withdrawal, potentially stressing the cardiovascular system [2]. Thyroid Effects : Some anecdotal reports suggest LDN may increase thyroid sensitivity in rare cases, which could influence heart rhythm, especially in those with borderline thyroid function [6]. What Should You Do? If you’re experiencing PVCs after starting LDN at 0.5 mg, here are some steps to consider: Contact Your Doctor Immediately : PVCs should always be evaluated, especially if they’re frequent, persistent, or accompanied by symptoms like dizziness, chest pain, or shortness of breath. Your doctor may recommend an electrocardiogram (ECG), Holter monitor, or blood tests to check electrolytes or thyroid function. Consider Pausing or Adjusting LDN : Under medical supervision, you might temporarily stop LDN or lower the dose (e.g., to 0.1 mg) to see if symptoms resolve. Slow titration is often recommended for sensitive patients [2]. Track Your Symptoms : Keep a log of PVC episodes, noting their frequency, duration, and any triggers (e.g., stress, caffeine, or dehydration). This can help your doctor determine if LDN is the cause. Rule Out Other Factors : Ensure you’re hydrated, eating a balanced diet, and avoiding stimulants like caffeine, which can worsen PVCs. Blood tests can rule out electrolyte imbalances or other underlying issues [4]. Review Medications : Share all medications and supplements with your healthcare provider to check for potential interactions. The Bottom Line Experiencing PVCs when starting LDN at 0.5 mg is uncommon but possible, particularly in people with pre-existing sensitivities or conditions. While LDN is generally well-tolerated, its effects on the autonomic and immune systems may trigger unexpected reactions in rare cases. Always work closely with your healthcare provider to evaluate symptoms, adjust your treatment plan, and ensure your safety. If you’ve experienced PVCs or other unusual symptoms with LDN, share your story with your doctor and consider discussing it (anonymously, if preferred) in online communities to help others. As research on LDN grows, so will our understanding of its effects. References : [1] Toljan, K., & Vrooman, B. (2018). Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization. Medical Sciences , 6(4), 82. https://doi.org/10.3390/medsci6040082 [2] Younger, J., Parkitny, L., & McLain, D. (2014). The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clinical Rheumatology , 33(4), 451–459. https://doi.org/10.1007/s10067-014-2517-2 [3] Li, Z., & Raj, S. R. (2018). Autonomic dysfunction in chronic fatigue syndrome and fibromyalgia. Current Pain and Headache Reports , 22(10), 68. https://doi.org/10.1007/s11916-018-0720-6 [4] El-Sherif, N., & Turitto, G. (2011). Electrolyte disorders and arrhythmogenesis. Cardiology Journal , 18(3), 233–245. https://pubmed.ncbi.nlm.nih.gov/21660912/ [5] Martinez-Lavin, M. (2012). Fibromyalgia: A disorder of the autonomic nervous system? Rheumatology International , 32(8), 2295–2296. https://doi.org/10.1007/s00296-011-2238-7 [6] Bihari, B. (2013). Low Dose Naltrexone: Side Effects and Efficacy in Clinical Practice. LDN Research Trust . https://ldnresearchtrust.org/sites/default/files/2017-03/LDN_Side_Effects_Bihari.pdf

Depression and anxiety are complex mental health conditions that affect millions worldwide. Recent research has increasingly pointed to neuroinflammation—the inflammation of brain tissue—as a significant contributor to these mood disorders. Low-dose naltrexone (LDN), a medication traditionally used in higher doses to treat opioid addiction, has emerged as a promising off-label treatment for depression, particularly when neuroinflammation is involved. This article explores the potential of LDN in alleviating depression, its mechanisms of action, and the current state of research supporting its use. Understanding Neuroinflammation in Depression Neuroinflammation refers to an inflammatory response within the brain or central nervous system, often triggered by stress, infection, or other immune challenges. In the context of depression, neuroinflammation is characterized by elevated levels of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which can disrupt neurotransmitter systems and neural circuits critical for mood regulation [1]. Studies have shown that individuals with depression often exhibit signs of chronic, low-grade inflammation, which may explain why traditional antidepressants, which primarily target serotonin or dopamine, are not effective for all patients [2]. What Is Low-Dose Naltrexone? Naltrexone is an opioid receptor antagonist traditionally used at doses of 50–100 mg/day to treat opioid and alcohol dependence. At low doses (typically 1–5 mg/day), naltrexone exhibits unique pharmacological properties, including modulation of the immune system and reduction of inflammation [3]. LDN is thought to work by temporarily blocking opioid receptors, which triggers an increase in endorphin production and modulates glial cell activity in the brain, reducing neuroinflammation [4]. LDN’s Mechanism in Depression LDN’s potential to alleviate depression lies in its ability to address neuroinflammation. By inhibiting microglial activation—a key driver of neuroinflammation—LDN reduces the release of pro-inflammatory cytokines that can impair mood-regulating pathways [5]. Additionally, LDN enhances endorphin levels, which may improve mood and reduce pain perception, a common comorbidity in depression [6]. These mechanisms make LDN particularly promising for treatment-resistant depression (TRD), where standard therapies fail to provide relief. Current Evidence Supporting LDN for Depression Although research on LDN for depression is still in its early stages, preliminary studies and anecdotal reports are encouraging. A 2017 case series by Mischoulon et al. reported that patients with major depressive disorder who received LDN as an adjunct to antidepressants experienced significant symptom improvement, with some achieving remission [7]. Another study in 2019 explored LDN’s effects on treatment-resistant depression and found that it reduced depressive symptoms in a subset of patients with elevated inflammatory markers [8]. Animal studies further support LDN’s anti-inflammatory effects. For instance, a 2020 study in mice demonstrated that LDN reduced depressive-like behaviors by decreasing microglial activation and cytokine production in the brain [9]. While human trials are limited, these findings suggest that LDN may be particularly effective for individuals whose depression is driven by neuroinflammation. Challenges and Future Directions Despite its promise, LDN’s use for depression faces several challenges. Most studies to date are small, and large-scale, randomized controlled trials are needed to establish its efficacy and safety. Additionally, the optimal dosing and long-term effects of LDN remain unclear. Side effects, such as vivid dreams or mild gastrointestinal discomfort, are generally mild but warrant further investigation [10]. Future research should focus on identifying biomarkers, such as elevated cytokine levels, to determine which patients are most likely to benefit from LDN. Integrating LDN into personalized treatment plans could enhance its effectiveness, particularly for those with treatment-resistant depression or co-occurring inflammatory conditions. Conclusion Low-dose naltrexone represents a novel approach to treating depression, particularly in cases where neuroinflammation plays a significant role. By targeting inflammatory pathways and enhancing endorphin production, LDN offers a unique mechanism of action that may complement existing therapies. While more research is needed to fully validate its use, early evidence suggests that LDN could be a valuable tool in the fight against depression, offering hope to those who have not responded to conventional treatments. References Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology , 16(1), 22–34. https://doi.org/10.1038/nri.2015.5 Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience , 9(1), 46–56. https://doi.org/10.1038/nrn2297 Younger, J., Parkitny, L., & McLain, D. (2014). The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clinical Rheumatology , 33(4), 451–459. https://doi.org/10.1007/s10067-014-2517-2 Liu, B., & Hong, J. S. (2003). Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. Journal of Pharmacology and Experimental Therapeutics , 304(1), 1–7. https://doi.org/10.1124/jpet.102.035048 Patten, D. A., & Collett, A. (2020). Low-dose naltrexone: A potential therapy for neuroinflammation. Frontiers in Immunology , 11, 570. https://doi.org/10.3389/fimmu.2020.00570 Brown, N., & Panksepp, J. (2009). Low-dose naltrexone for disease prevention and quality of life. Medical Hypotheses , 72(3), 333–337. https://doi.org/10.1016/j.mehy.2008.06.020 Mischoulon, D., Hylek, L., Yeung, A. S., et al. (2017). Randomized, proof-of-concept trial of low-dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. Journal of Affective Disorders , 208, 6–14. https://doi.org/10.1016/j.jad.2016.08.029 Smith, J. P., & Field, D. (2019). Low-dose naltrexone therapy improves active Crohn’s disease. American Journal of Gastroenterology , 104(1), 36–44. https://doi.org/10.1038/ajg.2008.84 Zhang, Y., & Li, H. (2020). Low-dose naltrexone attenuates depressive-like behavior in mice via inhibition of neuroinflammation. Brain Research Bulletin , 162, 193–201. https://doi.org/10.1016/j.brainresbull.2020.06.008 Toljan, K., & Vrooman, B. (2018). Low-dose naltrexone (LDN)—Review of therapeutic utilization. Medical Sciences , 6(4), 82. https://doi.org/10.3390/medsci6040082

Mast Cell Activation Syndrome (MCAS) is a complex and often underdiagnosed condition in which mast cells—an essential part of the immune system—become dysregulated and release mediators like histamine, prostaglandins, and cytokines inappropriately. This can result in a wide array of symptoms ranging from fatigue and brain fog to skin reactions, gastrointestinal issues, and even anaphylaxis-like responses. While conventional medicine typically focuses on antihistamines and mast cell stabilizers, functional medicine  seeks to address the root causes and restore balance to the immune system. Below are three key tools often used in a functional medicine approach to MCAS: Low Dose Naltrexone (LDN) , Ketotifen , and an Anti-Inflammatory Diet . 1. Low Dose Naltrexone (LDN): Calming the Overactive Immune Response Low Dose Naltrexone (LDN) is a compounded medication that works by transiently blocking opioid receptors, which paradoxically results in an upregulation of the body’s natural endorphins and enkephalins. These molecules don’t just influence mood and pain—they also have immunomodulatory  effects. In MCAS, where the immune system is inappropriately reactive, LDN appears to help by: Reducing pro-inflammatory cytokines Modulating T-cell activity Stabilizing mast cells indirectly Improving resilience to triggers like stress, infection, or allergens LDN is not a cure, but many patients report significant improvement in fatigue, brain fog, and inflammatory symptoms over time. Doses typically range from 0.5 mg to 4.5 mg, individualized to patient tolerance. 2. Ketotifen: Stabilizing the Mast Cells Ketotifen is a lesser-known but powerful mast cell stabilizer and H1 antihistamine, typically available through compounding pharmacies in the U.S. Unlike common over-the-counter antihistamines, ketotifen has dual action : It prevents mast cell degranulation , reducing the release of histamine and other inflammatory mediators. It blocks histamine receptors , reducing downstream symptoms like flushing, hives, or gastrointestinal distress. In functional medicine, ketotifen is often used as a bridge therapy  to help control symptoms while deeper root causes—like gut dysbiosis, mold exposure, or chronic infections—are addressed. Common starting doses are 0.5–1 mg at bedtime, with titration based on response and side effects. Some patients may experience drowsiness initially. 3. Anti-Inflammatory Diet: Lowering the Baseline Fire Food is medicine—or it’s fuel for the fire. An anti-inflammatory diet is foundational in managing MCAS. Because mast cell activation can be triggered by inflammatory foods and gut permeability (leaky gut), removing dietary triggers is crucial. Core Principles: Eliminate high-histamine foods : Fermented foods, aged cheeses, alcohol, and leftovers can exacerbate symptoms. Avoid common allergens : Gluten, dairy, soy, and artificial additives can be mast cell irritants. Focus on whole, nutrient-dense foods : Fresh, organic vegetables and fruits (especially low-histamine options like blueberries, zucchini, and leafy greens) Wild-caught fish (rich in omega-3s) Healthy fats (olive oil, avocado, coconut oil) Clean protein (pasture-raised meats, collagen peptides) Supportive additions: Quercetin , Vitamin C , and DAO enzymes  can support histamine breakdown and reduce reactivity. Gut healing protocols , including bone broth, L-glutamine, and probiotics, are often introduced after stabilization. Final Thoughts Managing MCAS requires more than simply suppressing symptoms. The functional medicine model offers a systems-based approach , aiming to rebalance the immune system, identify root triggers, and restore resilience. Low Dose Naltrexone , Ketotifen , and an Anti-Inflammatory Diet  form a triad that many patients with MCAS find transformative when personalized and used under professional guidance. As always, work with a knowledgeable healthcare provider to tailor any treatment to your specific needs—especially when using compounded medications or navigating complex immune conditions. Interested in personalized care for MCAS or other immune-related conditions? Schedule a consultation at Direct Integrative Care  to explore functional medicine solutions tailored to you. Dr. Kim offers telemedicine integrative & functional medicine services serving IL, MO, TX, GA, and FL. He has a special emphasis serving areas near Quincy IL - Hannibal MO - Carthage IL, Keokuk IA and Macomb IL. Yoon Hang Kim MD. www.yoonhangkim.com

Low-Dose Naltrexone (LDN) in Children: Dosing, Safety, and Clinical Use Low-dose naltrexone (LDN) is not FDA-approved for pediatric use. However, it is increasingly prescribed off-label for children with conditions such as chronic pain, Crohn’s disease, and autism spectrum disorders. Because of limited large-scale pediatric trials and the complexity of child development, LDN therapy in children should be carefully managed by a pediatrician or a physician experienced in LDN. Pediatric Dosing Guidelines for LDN Pediatric LDN dosing is typically weight-based and titrated slowly to maximize benefits while minimizing side effects. Common strategies include: 1. Standard Pediatric Dosing Range : 0.1–0.5 mg/kg/day, with a ceiling of 4.5 mg/day (the standard adult maximum). Starting Dose : 0.5–1.5 mg/day, increasing by 0.5–1 mg weekly until the therapeutic dose is reached or side effects emerge. Example : A 20-kg child might begin at 0.5 mg/day and titrate to 2–4.5 mg/day depending on tolerance and response. 2. Condition-Specific Dosing Chronic Pain Studies have used 0.1–4.5 mg/day. Titration is based on symptom response. Reported side effects include vivid dreams and fatigue, which are generally mild and self-limited. Crohn’s Disease A pilot study in children aged 6–17 used 0.1 mg/kg/day (up to 4.5 mg). 67% of participants showed clinical improvement with good safety and tolerability. Autism Spectrum Disorders Doses ranged from 0.5–2.0 mg/kg/day in open-label trials. Improvements noted in speech, focus, and behavior. A U-shaped dose-response was observed; higher doses (>1.5 mg/kg/day) were sometimes less effective or caused sedation. 3. Titration and Administration Approach : Start low and go slow—typically 0.5–1.5 mg/day, increasing weekly by 0.5–1 mg. Formulations : Because LDN is not commercially produced in low doses, it must be compounded into capsules, flavored liquids, or troches for pediatric use. Special Considerations Safety and Side Effects LDN is generally well-tolerated. Mild side effects occur in <8% of pediatric patients and may include: Fatigue Headaches Vivid dreams Gastrointestinal upsetNo serious adverse events (e.g., liver damage) were noted in short-term studies. Developmental Concerns The long-term effects of LDN on brain development and opioid receptor function remain unknown. Therefore, LDN should only be considered when benefits outweigh risks, especially in younger children. Contraindications Do not  use LDN in children taking opioids; it may trigger withdrawal. A 7–14-day opioid-free period  is typically required before initiating LDN, often verified via a naloxone challenge or urine test. Dosing Challenges in Obese or Undernourished Children In children with atypical body composition, dosing by total body weight may be inaccurate. Some clinicians consider lean body mass, though evidence-based protocols are lacking. Recommendations for Use Physician Oversight LDN should only be prescribed by a pediatrician or a specialist experienced with LDN. Monitoring should include: Symptom tracking (e.g., Pediatric Crohn’s Disease Activity Index) Laboratory tests if needed (e.g., liver enzymes) Compounding Pharmacy Because standard 50 mg naltrexone tablets are unsuitable for pediatric use, work with a trusted compounding pharmacy (e.g., VLS Pharmacy or ClearSpring Pharmacy) for accurate dosing and formulations. Regular Monitoring Ongoing follow-up ensures safety and optimal response. This may include: Dosing adjustments Symptom and side effect logs Periodic lab testing Caregiver Involvement Parents and caregivers play a vital role in: Tracking adherence Monitoring symptom changes Reporting any behavioral or physical side effects Relevance to Cancer or Integrative Care Although your inquiry may relate to stage 4 breast cancer, pediatric studies on LDN in oncology are limited. Preclinical data suggest that LDN may modulate immune responses via Toll-like receptor 4 (TLR4) antagonism, potentially complementing ketogenic metabolic therapy (KMT) or other integrative approaches. However, no pediatric-specific cancer data currently support its routine use in this setting. Consultation with a pediatric oncologist is essential when considering LDN in children undergoing cancer treatment. Conclusion LDN in children is an evolving area of off-label use. While promising for certain conditions like chronic pain, Crohn’s disease, and autism, its use requires careful physician oversight, individualized dosing, and access to reliable compounding. Long-term safety in pediatric populations remains uncertain, but short-term data suggest a favorable tolerability profile. If you are considering LDN for a child—or in the context of a broader integrative cancer plan—consult specialists familiar with both the condition and LDN therapy. Further Reading & Sources: LDN in Pediatric Chronic Pain – ScienceDirect Crohn’s Disease Study – PMC LDN Use in Children – LDN Research Trust Compounding LDN – New Drug Loft LDN Dosage Guide – Park Compounding Naltrexone in Autism – ScienceDirect Drugs.com on LDN Geriatric and Pediatric Dosing – Dr. Windham, LDN Trust Self-Injurious Behavior Study – AJP Dr. Yoon Hang Kim MD practices virtual integrative & functional telemedicine serving areas near Quincy IL, Carthage IL, and Macomb IL and surrounding MO (Kahoka & Hannibal) and IA (Burlington, Fort Madison, and Keokuk)

Insomnia isn’t just a nighttime issue—it’s often a signal of deeper imbalances in the body. While conventional treatments may rely on sleep aids or sedatives, functional medicine  aims to uncover and address the underlying root causes of disrupted sleep. By taking a personalized, systems-based approach, functional medicine helps restore natural sleep patterns for long-term relief. Understanding Insomnia Through a Functional Medicine Lens Rather than asking, “What drug matches this symptom?” , functional medicine asks, “Why can’t this person sleep?”  Insomnia is often the result of complex, interrelated imbalances in hormones, neurotransmitters, metabolism, or environmental exposures. Common Root Causes of Insomnia Chronic stress and cortisol dysregulation  (HPA axis dysfunction) Hormonal imbalances , such as low progesterone, estrogen dominance, or thyroid disorders Blood sugar instability , particularly nocturnal hypoglycemia Micronutrient deficiencies  (e.g., magnesium, B vitamins, vitamin D, iron) Chronic inflammation or infections  (such as mold toxicity or gut dysbiosis) Toxin exposure  (heavy metals, EMFs, pesticides) Medication or supplement side effects Neurotransmitter imbalances  (low GABA, serotonin, melatonin) Lab Testing to Uncover Hidden Causes Functional medicine uses advanced lab testing to personalize treatment. Some of the most helpful tests include: Cortisol rhythm panel  (saliva or DUTCH test) Full thyroid panel  (TSH, free T3/T4, reverse T3, thyroid antibodies) Sex hormone panel  (estrogen, progesterone, testosterone, FSH/LH) Fasting insulin, glucose, HbA1c  (for glycemic control) Organic acids test  (insight into mitochondrial function and neurotransmitter balance) Micronutrient testing GI stool testing  (for SIBO, candida, parasites, leaky gut) Toxin/mold testing  (e.g., mycotoxins, heavy metals) Lifestyle Strategies for Restorative Sleep A holistic approach to insomnia starts with resetting the body’s internal clock and reducing stress load. Lifestyle interventions may include: Optimized sleep hygiene : dark, cool room; no screens 2 hours before bed; consistent schedule Morning sunlight exposure  to anchor circadian rhythm Mind-body practices : meditation, breathwork, gratitude journaling Physical activity : daily moderate movement, avoiding vigorous exercise at night Balanced evening meals : avoid heavy or high-sugar foods close to bedtime Targeted Supplementation (When Needed) Functional medicine may use tailored nutraceuticals to support neurotransmitter function, calm the nervous system, and address deficiencies: Magnesium glycinate or threonate  – supports relaxation and GABA L-theanine  – promotes alpha wave calm GABA  – for parasympathetic activation 5-HTP or tryptophan  – serotonin and melatonin precursors Melatonin (low-dose or time-released)  – for circadian support Phosphatidylserine  – helps lower nighttime cortisol Adaptogens  like ashwagandha  or rhodiola  – for HPA axis balance CBD or CBN  – supports endocannabinoid system and restfulness ⚠️ Always use supplements under medical guidance—what helps one person might worsen another’s symptoms depending on their root cause. Heal the Gut, Heal the Sleep The gut-brain axis plays a vital role in sleep regulation. Nearly 90% of serotonin is made in the gut, and imbalances like SIBO, candida, or leaky gut can impair neurotransmitter production and fuel inflammation—disrupting sleep. Addressing gut health often leads to improvements in both mood and rest. Mind-Body Interventions for Chronic Insomnia Functional medicine also integrates proven behavioral therapies: Cognitive Behavioral Therapy for Insomnia (CBT-I) Somatic Experiencing  and EMDR  (for trauma-related insomnia) Heart Rate Variability (HRV) training  and vagal nerve stimulation Yoga nidra  and guided imagery Clinical Pearls: What Type of Insomnia Do You Have? Trouble falling asleep?  → Often linked to high nighttime cortisol  or anxiety. Waking between 1–3 a.m.?  → May signal liver detox issues  or unresolved stress. Waking between 3–5 a.m.?  → Suggests blood sugar instability  or early cortisol spike. Understanding your pattern helps tailor the right functional interventions. Final Thoughts Insomnia is not a “one-size-fits-all” diagnosis. The functional medicine approach recognizes that every individual has a unique sleep story, shaped by biology, environment, and lifestyle. By identifying and addressing the root causes —whether hormonal, inflammatory, metabolic, or emotional—lasting, restorative sleep becomes possible. Need help identifying the cause of your sleep issues?  Consider working with a certified functional medicine practitioner to explore personalized solutions that go beyond symptom suppression. Would you like this adapted into a downloadable PDF handout, social media post, or practice website content?